Table 2.
Association analysis results between TEAD CNVs and prognosis in glioma
| Gene | LGG | GBM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| INC | NOR | DEC | OS p | DFS p | INC | NOR | DEC | OS p | DFS p | |
| TEAD1 | 2 | 497 | 14 | 0.165 | 0.988 | 0 | 575 | 1 | NA | NA |
| TEAD2 | 1 | 496 | 16 | 0.791 | 0.132 | 3 | 573 | 1 | 0.857 | 0.882 |
| TEAD3 | 5 | 508 | 0 | 0.918 | 0.004 | 2 | 576 | 0 | NA | NA |
| TEAD4 | 28 | 484 | 1 | 0.074 | 0.010 | 9 | 567 | 1 | 0.815 | 0.463 |
Note: p value was calculated by log-rank method, the p values less than 0.1 were in bold. If the sample size of a group was less than 3, the group was deleted. INC represents CNV increase; NOR represents normal; DEC represents CNV decrease.